ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för icatibant. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

20 träffar

Bibliografisk träff 2012-09-13

Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.

Charignon D, Späth P, Martin L, Drouet C.

Expert Opin Pharmacother · research support, non-u.s. gov't; review; journal article · DOI 10.1517/14656566.2012.723692

Bibliografisk träff 2012-09-07

Vasodilator and antihypertensive effects of a novel N-acylhydrazone derivative mediated by the inhibition of L-type Ca²⁺ channels.

Pereira SL, Kummerle AE, Fraga CA, Barreiro EJ, Sudo RT, Zapata-Sudo G.

Fundam Clin Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1472-8206.2012.01076.x

Bibliografisk träff 2012-08-30

Icatibant and ACE inhibitor angioedema.

Illing EJ, Kelly S, Hobson JC, Charters S.

BMJ Case Rep · journal article; case reports; case-report · DOI 10.1136/bcr-2012-006646

Bibliografisk träff 2012-07-26

The bradykinin B(2) receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines.

Kramarenko II, Morinelli TA, Bunni MA, Raymond JR, Garnovskaya MN.

Cancer Manag Res · research-article; journal article · DOI 10.2147/cmar.s31847

Bibliografisk träff 2012-07-15

The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.

Salie R, Moolman JA, Lochner A.

Basic Res Cardiol · journal article · DOI 10.1007/s00395-012-0281-5

Bibliografisk träff 2012-06-12

Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.

Zanichelli A, Bova M, Coerezza A, Petraroli A, Triggiani M, Cicardi M.

Allergy · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1398-9995.2012.02853.x

Bibliografisk träff 2012-06-01

Safety and efficacy of icatibant self-administration for acute hereditary angioedema.

Boccon-Gibod I, Bouillet L.

Clin Exp Immunol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1365-2249.2012.04574.x

Bibliografisk träff 2012-06-01

Renin-angiotensin system inhibitors and angioedema: anesthetic implications.

Stojiljkovic L.

Curr Opin Anaesthesiol · review; journal article · DOI 10.1097/aco.0b013e328352dda5

Bibliografisk träff 2012-06-01

Update on treatment of hereditary angioedema.

Buyantseva LV, Sardana N, Craig TJ.

Asian Pac J Allergy Immunol · review; journal article

Bibliografisk träff 2012-05-09

Gangliosides stimulate bradykinin B2 receptors to promote calmodulin kinase II-mediated neuronal differentiation.

Kanatsu Y, Chen NH, Mitoma J, Nakagawa T, Hirabayashi Y, Higashi H.

J Biochem · research support, non-u.s. gov't; journal article · DOI 10.1093/jb/mvs055

Bibliografisk träff 2012-05-01

Successful perioperative management of a patient with C1 esterase inhibitor deficiency with a novel bradykinin receptor B2 antagonist.

Senaratne KT, Cottrell AM, Prentice RI.

Anaesth Intensive Care · journal article; case reports · DOI 10.1177/0310057x1204000320

Bibliografisk träff 2012-05-01

Discrepancies between guidelines and international practice in treatment of hereditary angioedema.

Dispenza MC, Craig TJ.

Allergy Asthma Proc · research support, non-u.s. gov't; journal article · DOI 10.2500/aap.2012.33.3566

Bibliografisk träff 2012-05-01

Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.

Bernstein JA, Moellman JJ.

Postgrad Med · review; journal article · DOI 10.3810/pgm.2012.05.2552

Bibliografisk träff 2012-04-30

Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity.

Yao Y, Sheng Z, Li Y, Yan F, Fu C, Li Y, Ma G, Liu N, Chao J, Chao L.

Hum Gene Ther · research support, non-u.s. gov't; research-article; journal article · DOI 10.1089/hum.2011.123

Bibliografisk träff 2012-03-20

Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow.

Mordwinkin NM, Meeks CJ, Jadhav SS, Espinoza T, Roda N, diZerega GS, Louie SG, Rodgers KE.

Endocrinology · research-article; journal article; research support, n.i.h., extramural · DOI 10.1210/en.2011-2031

Bibliografisk träff 2012-03-02

Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.

Riedl M.

Clin Ther · research support, non-u.s. gov't; journal article · DOI 10.1016/j.clinthera.2012.02.003

Bibliografisk träff 2012-01-01

Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.

Firinu D, Barca MP, Serusi L, Lorrai MM, Peralta MM, Manconi PE, Del Giacco SR.

Int J Immunopathol Pharmacol · letter; research support, non-u.s. gov't; case reports · DOI 10.1177/039463201202500130

Bibliografisk träff 2012-01-01

[Hereditary angioedema. A therapeutic guide].

Malbrán A, Fernández Romero DS, Menéndez A.

Medicina (B Aires) · practice guideline; journal article; english abstract

Bibliografisk träff 2011-12-06

Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistamines.

Maurer M, Church MK.

Exp Dermatol · letter; clinical trial; research support, non-u.s. gov't · DOI 10.1111/j.1600-0625.2011.01410.x

Bibliografisk träff 2011-09-30

Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1.

Yu HZ, Xie LD, Zhu PL, Xu CS, Wang HJ.

Mol Cell Biochem · research support, non-u.s. gov't; journal article · DOI 10.1007/s11010-011-1076-y